Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7425 p535-541
4 November 2006

This section
Reprint   Photocopy

PDF 180K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events

Pages: 535   536   537   538   539   540   541 

535 Greater interprofessional co-operation is needed Insufficient co-operation between health professionals threatens service improvements, the All Party Pharmacy Group warned following last week’s evidence session for its inquiry into the future of pharmacy
PJ 2006;277:535
Full Text

535 More consistent approach to patient safety across the NHS required Patient safety must be emphasised more consistently within the NHS, according to this year’s State of Healthcare Report, published by the Healthcare Commission this week
PJ 2006;277:535
Full Text

535 Health minister open to care record access Health minister Andy Burnham has agreed to raise the issue of pharmacists’ access to the NHS Care Record database with Lord Warner, the minister responsible for IT. The assurance came during a meeting of the All-Party Parliamentary Group for Patient Safety held in London last week
PJ 2006;277:535
Full Text

535 Society warns of pharmacist’s behaviour Pharmacy employers have been alerted to the behaviour of a pharmacist who violently attacked a member of the Royal Pharmaceutical Society’s staff after being told that he was to be struck off the Register for professional misconduct
PJ 2006;277:535
Full Text

536 Twice-daily deliveries at risk if others follow Pfizer arrangements Twice-daily deliveries to pharmacies would be threatened if other manufacturers follow Pfizer’s lead in changing supply arrangements, MP Sandra Gidley (Lib Dem, Romsey) warned this week
PJ 2006;277:536
Full Text

536 PSNC calls for national minor ailments service National implementation of a minor ailments service as an essential service under the new pharmacy contract has been called for by the Pharmaceutical Services Negotiating Committee
PJ 2006;277:536
Full Text

536 Wholesaler rift widens as European meeting disrupted Alliance Boots’s wholesale and commercial affairs director, Ornella Barra, is accused this week of disrupting a European Association of Pharmaceutical Full-line Wholesalers (GIRP) meeting, which took place in Brussels
PJ 2006;277:536
Full Text

536 Guild of Healthcare Pharmacists calls again for recruitment and retention premiums The Guild of Healthcare Pharmacists has once again called for recruitment and retention premiums of up to £4,244 for hospital pharmacists
PJ 2006;277:536
Full Text

537 DoH figures indicate PBC progress Primary care trusts and GP practices continue to make progress towards adopting practice-based commissioning (PBC), according to figures released by the Department of Health last week. However, whether PCTs are truly engaging in practice-based commissioning has been questioned
PJ 2006;277:537
Full Text

537 Erewash self care project changes attitude more than behaviour Significant changes in the public’s attitude to self care have been achieved by a 12-month project commissioned by the Proprietary Association of Great Britain. But the change in attitude has only been matched by minor changes in behaviour
PJ 2006;277:537
Full Text

537 Guideline highlights legal implications of crushing tablets Crushing tablets or opening capsules should only be carried out as a last resort and could have important medical and legal consequences, according to a consensus guideline for the medicines management of people with dysphagia published last week
PJ 2006;277:537
Full Text

538 Patient groups should disclose financial support A survey of patient groups based in the US has revealed that seven of 29 groups received at least 20 per cent of their funding from pharmaceutical and medical device companies
PJ 2006;277:538
Full Text

538 Involve patients in CV disease prevention decisions, say experts Aggressive cardiovascular disease prevention strategies are “medicalising” patients but without involving them in understanding the risks, experts suggest
PJ 2006;277:538
Full Text

538 WHO initiative to combat medicines-related corruption Anti-corruption specialists are to join experts in medicines in a new initiative launched by the World Health Organization
PJ 2006;277:538
Full Text

538 New agreement defines counterfeiting as serious crime Counterfeiting medicines is to be defined as a serious crime under plans for a new convention announced by the Council of Europe
PJ 2006;277:538
Full Text

538 NHS fraudsters face parallel actions under new policy Health professionals who defraud the NHS are to face criminal, professional disciplinary and civil recovery proceedings all at the same time, the NHS Counter Fraud and Security Management Service has announced
PJ 2006;277:538
Full Text

539 Greater focus on needle exchange schemes needed The prevalence of HIV infection in injecting drug users (IDUs) is around double that seen at the beginning of the decade, a recent report reveals
PJ 2006;277:539
Full Text

539 Poor results for methadone programme in Scotland, report researchers Questions over the effectiveness of the methadone programme in Scotland were posed this week by researchers from Glasgow
PJ 2006;277:539
Full Text

539 Dispensing doctors want one register for all dispensing staff There should be one register that covers all dispensing staff, no matter where they work, the Dispensing Doctors’ Association suggests in its response to the Foster review of non-medical regulation
PJ 2006;277:539
Full Text

540 Further evidence suggests neutral effect of statins on risk of cancer Further evidence to suggest that statins are not associated with an increased or decreased risk of cancer has emerged in a meta-analysis published in the Journal of Clinical Oncology
PJ 2006;277:540
Full Text

540 Once daily mesalazine induces remission in colitis A new 5-aminosalicylic acid (5-ASA) drug formulation for ulcerative colitis is likely to be launched in the UK next year, allowing once daily dosing for a condition in which compliance is a particular problem
PJ 2006;277:540
Full Text

540 Review supports protective effect of COX-2s but not statins against colorectal cancer Patients who take cyclo-oxygenase-2 (COX-2) inhibitors have a reduced risk of developing colorectal cancer (CRC), suggests a retrospective analysis of UK general practice data
PJ 2006;277:540
Full Text

540 New musculoskeletal framework Primary care trusts will want to exploit all opportunities for increasing the input and influence of pharmacists and community pharmacies to support the improved care of people with musculoskeletal conditions, according to new guidance
PJ 2006;277:540
Full Text

540 Chlamydia screening on track Chlamydia screening has increased by over a third in the past year, according to the National Chlamydia Screening Programme 2005–06 annual report
PJ 2006;277:540
Full Text

541 Anti-obesity drugs needed unless attitudes change Unless there is a complete revision of attitudes to obesity, drug therapies should continue to play an important role in treatment, the authors of a Lancet article published online on 27 October argue
PJ 2006;277:541
Full Text

541 Rimonabant leads to modest weight loss, Cochrane review concludes Use of rimonabant for one year could produce moderate weight loss of about 5 per cent, according to a Cochrane review of the anti-obesity drug, which was launched in the UK earlier this year
PJ 2006;277:541
Full Text

541 MHRA rules that Superdrug advertisements were illegal Superdrug broke the law on medicines advertising earlier this year in its summer magazine, the Medicines and Healthcare products Regulatory Agency has ruled
PJ 2006;277:541
Full Text

541 Nucare members struggle since control of entry change Many independent pharmacies do not find it financially viable to open on Saturdays, Nucare has pointed out in its response to the Department of Health’s review of pharmacy control-of-entry reforms
PJ 2006;277:541
Full Text

541 All Wales business rate relief scheme will help pharmacy Adoption of an all Wales small business rate relief scheme will support the existence of the community pharmacy as an important part of the local business infrastructure, says the National Pharmacy Association in its response to the Welsh Assembly Government’s consultation on plans to introduce the scheme
PJ 2006;277:541
Full Text

Back to Top


©The Pharmaceutical Journal